Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Emelly Rusli"'
Publikováno v:
Bioengineering, Vol 11, Iss 8, p 846 (2024)
Treatment for breast cancer (BC) can lead to debilitating symptoms that can reduce outcomes and quality of life (QoL). Symptom surveillance using a remote symptom monitoring (RSM) platform enables the capture and reporting of patient-reported outcome
Externí odkaz:
https://doaj.org/article/41378120b0214267868195f59ef2e5b7
Autor:
Vicki K. Wing, Philippe Martin, Aaron Galaznik, Li Shi, Emelly Rusli, Lilia Bouzit, Chelsea Vigna, Caleb Ball, Rahul Jain
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-179
Autor:
Robert R Buderi, Emelly Rusli, Vicki K Wing, Sheila S Diamond, Bhargav Koduru, Alexandru Socolov, Vibhu Agarwal, Jacob Aptekar, Rahul Jain, Aaron Galaznik, David C Fajgenbaum
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:EPR22-107
Publikováno v:
Gastrointestinal Endoscopy. 95:AB411
Publikováno v:
Gastroenterology. 162:S-338
Autor:
Emelly Rusli, Aniketh Talwai, Vibhu Agarwal, Jacob Aptekar, Yahav Itzkovich, Aaron Galaznik, Robert Buderi, Lilia Bouzit, Alexandru Socolov
Publikováno v:
Blood. 138:4826-4826
Background: Despite the potential for durable disease remission seen with Chimeric Antigen Receptor (CAR-T) and T-Cell Receptor (TCR-T) therapies, their use is limited by the potential for acute toxicity from Cytokine-Release Syndrome (CRS).Across al
Publikováno v:
Journal of Clinical Oncology. 39:6589-6589
6589 Background: While patients with cancer are known to be at increased risk of infection in part due to the immunocompromising nature of cancer treatments, recent data indicate a particularly high risk for COVID-19 infection and poor outcomes (Wang
Autor:
Jingshu Liu, G. Caleb Alexander, Ron G. Katriel, Sheila Diamond, Emelly Rusli, Elizabeth B. Lamont, Lisa Ensign
Publikováno v:
JAMA Netw Open
JAMA Network Open
JAMA Network Open
This cohort study evaluates the association of the coronavirus disease 2019 (COVID-19) pandemic with clinical research and development for cancer by studying the initiation of oncology clinical trials over time.
Autor:
Lisa Ensign, Mona A Kelkar, Aaron Galaznik, Emelly Rusli, Lihong Diao, Mark F. Watson, Cynthia Liu
Publikováno v:
Blood. 136:9-9
Background: Past studies have indicated a potential racial disparity in Multiple Myeloma (MM) survival between black and white patients (Costa et al., 2017; Marinac et al., 2020), an issue compounded by minority underrepresentation in clinical trials
Publikováno v:
Blood. 134:5900-5900
BACKGROUND: Despite an increasing number of treatment options available and in development, Relapsed-Refractory Multiple Myeloma (RRMM) remains an incurable disease with survival less than 12 months (Kumar SK et al., 2012). In a recent study by Morea